NCT06771713 Brief Pain Reprocessing Therapy in Veterans
| NCT ID | NCT06771713 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Michigan |
| Condition | Chronic Lower Back Pain (CLBP) |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-03-10 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-03-10 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research is studying whether a Zoom-based behavioral intervention may have an impact as a treatment for Veterans with Chronic Low Back Pain (CLBP). The study will examine: * The acceptability of the Brief Pain Reprocessing Therapy (BPRT) intervention * The feasibility of the BPRT intervention * The safety of the BPRT intervention
Eligibility Criteria
Inclusion Criteria: * Low back pain that has lasted greater than 6 months, with pain on at least half of these days * Must provide verification of being an Armed Service Veteran. * Able to read, write and speak English * Internet access and audio-conferencing capability (e.g., Zoom meetings by phone or computer) in the home Exclusion Criteria: * Self-reported evidence of a separate medical condition (e.g., rheumatoid arthritis), acute injury in the past 12 months (e.g., self-reported spinal fracture), self-reported loss of bowel or bladder control in the past year (which may indicate presence of cauda equina syndrome), or evidence of presence of a metastasizing cancer requiring treatment * Pending surgical procedures or interventional therapies (e.g., spinal injections) within the next 12 months * Confirmed/suspected pregnancy * Evidence of other conditions that may preclude participants from understanding or being able to participate in study procedure (e.g., schizoaffective disorder, suspected or diagnosed dementia) * Currently receiving cognitive-behavioral therapy or other psychological therapies for pain * Open litigation in the past 1 year, as assessed in preliminary study screening. * Any other diseases or conditions that would make a patient unsuitable for study participation as determined by the site principal investigators.
Contact & Investigator
John Sturgeon, PhD
PRINCIPAL INVESTIGATOR
University of Michigan
Frequently Asked Questions
Who can join the NCT06771713 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Lower Back Pain (CLBP). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06771713 currently recruiting?
Yes, NCT06771713 is actively recruiting participants. Contact the research team at BPRTVeterans@med.umich.edu for enrollment information.
Where is the NCT06771713 trial being conducted?
This trial is being conducted at Ann Arbor, United States.
Who is sponsoring the NCT06771713 clinical trial?
NCT06771713 is sponsored by University of Michigan. The principal investigator is John Sturgeon, PhD at University of Michigan. The trial plans to enroll 50 participants.